3,4-Methylenedioxy-N-isopropylamphetamine

3,4-Methylenedioxy-N-isopropylamphetamine
Names
	Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-(propan-2-yl)propan-2-amine
	Other names 3,4-Methylenedioxy-N-isopropylamphetamineamine; 3,4-Methylenedioxy-1-(alpha-methyl-amino-isopropyl)-ethane
Identifiers
CAS Number	74698-37-6 ;
3D model (JSmol)	Interactive image;
ChemSpider	2319184;
PubChem CID	3057996;
UNII	307EH7224K ;
CompTox Dashboard (EPA)	DTXSID40388899 ;
	InChI InChI=1S/C13H19NO2/c1-9(2)14-10(3)6-11-4-5-12-13(7-11)16-8-15-12/h4-5,7,9-10,14H,6,8H2,1-3H3 Key: XKEVWMVUIDDRMC-UHFFFAOYSA-N;
	SMILES C1=C2C(=CC=C1CC(C)NC(C)C)OCO2;
Properties
Chemical formula	C13H19NO2
Molar mass	221.300 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

3,4-Methylenedioxy-N-isopropylamphetamine (MDIP, MDIPA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes which acts as an entactogen, psychedelic, and stimulant. It is the N-isopropyl analogue of 3,4-methylenedioxyamphetamine (MDA). MDIP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 250 mg.^[1] MDIP produces a mild threshold. Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of MDIP.

References

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.